Trial Profile
Phase II study of perifosine in patients with refractory and relapsed leukemia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2006
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 24 Mar 2006 New trial record.